Rocket Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell RCKT and other ETFs, options, and stocks.

About RCKT

Rocket Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the development of gene therapy treatment options for rare and devastating pediatric diseases. Its multi-platform development approach applies the lentiviral vector and adeno-associated viral vector gene therapy platforms. 

CEO
Gaurav D. Shah
CEOGaurav D. Shah
Employees
299
Employees299
Headquarters
Cranbury, New Jersey
HeadquartersCranbury, New Jersey
Founded
1999
Founded1999
Employees
299
Employees299

RCKT Key Statistics

Market cap
326.45M
Market cap326.45M
Price-Earnings ratio
-1.27
Price-Earnings ratio-1.27
Dividend yield
Dividend yield
Average volume
3.27M
Average volume3.27M
High today
$3.43
High today$3.43
Low today
$3.03
Low today$3.03
Open price
$3.32
Open price$3.32
Volume
4.01M
Volume4.01M
52 Week high
$26.98
52 Week high$26.98
52 Week low
$2.19
52 Week low$2.19

RCKT News

TipRanks 2d
Rocket Pharmaceuticals Receives FDA RMAT Designation

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...

Analyst ratings

56%

of 18 ratings
Buy
55.6%
Hold
38.9%
Sell
5.6%

People also own

Based on the portfolios of people who own RCKT. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.